Prof. Carmen Criscitiello is an associate professor at the University of Milan and a scientist and senior physician appointed with High Specialty in Immunotherapy at the Division of Early Drug Development at the European Institute of Oncology in Milan, Italy. She is a clinician and researcher committed to early drug development for patients with solid tumors, with a special interest in breast cancer. She has been a member of the ESMO Breast Cancer Faculty since 2017, Deputy Chair of the ESMO Leadership Generation Task Force since 2020, a Member of the ESMO Press & Media Affairs Committee since 2018, and an AIOM Breast Cancer Guidelines Panel Member since 2018. She serves as an Associate Editor of the Frontiers in Oncology and ESMO Open—Cancer Horizons. She is the global principal investigator of the international and multicentric ALPHABET study.